| pubmed-article:21134221 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21134221 | lifeskim:mentions | umls-concept:C0011615 | lld:lifeskim |
| pubmed-article:21134221 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:21134221 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
| pubmed-article:21134221 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:21134221 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:21134221 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21134221 | pubmed:dateCreated | 2011-6-29 | lld:pubmed |
| pubmed-article:21134221 | pubmed:abstractText | Toll-like receptor 2 gene (TLR2) –16934A>T polymorphism has been shown to be associated with severity of atopic dermatitis (AD) as measured using severity scoring of atopic dermatitis (SCORAD) index. Moreover, TLR2–16934A>T polymorphism has been associated with atopy and allergic disorders in farmers’ children. | lld:pubmed |
| pubmed-article:21134221 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21134221 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21134221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21134221 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21134221 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21134221 | pubmed:issn | 1468-3083 | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:OkumuraKK | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:NishiyamaCC | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:UndasAA | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:Wojas-PelcAA | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:PotaczekD PDP | lld:pubmed |
| pubmed-article:21134221 | pubmed:author | pubmed-author:NastalekMM | lld:pubmed |
| pubmed-article:21134221 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21134221 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:21134221 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21134221 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21134221 | pubmed:pagination | 715-21 | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:meshHeading | pubmed-meshheading:21134221... | lld:pubmed |
| pubmed-article:21134221 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21134221 | pubmed:articleTitle | An association of TLR2–16934A>T polymorphism and severity/phenotype of atopic dermatitis. | lld:pubmed |
| pubmed-article:21134221 | pubmed:affiliation | Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan. | lld:pubmed |
| pubmed-article:21134221 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21134221 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:7097 | entrezgene:pubmed | pubmed-article:21134221 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21134221 | lld:entrezgene |
